Literature DB >> 30786212

Prevention of Opioid Abuse and Treatment of Opioid Addiction: Current Status and Future Possibilities.

Kinam Park1, Andrew Otte1.   

Abstract

Prescription opioid medications have seen a dramatic rise in misuse and abuse, leading regulators and scientists to develop policies and abuse-deterrent technologies to combat the current opioid epidemic. These abuse-deterrent formulations (ADFs) are intended to deter physical and chemical tampering of opioid-based products, while still providing safe and effective delivery for therapeutic purposes. Even though formulations with varying abuse-deterrent technologies have been approved, questions remain about their effectiveness. While these formulations provide a single means to combat the epidemic, a greater emphasis should be placed on formulations for treatment of addiction and overdose to help those struggling with opioid dependence. This article analyzes various ADFs currently in clinical use and explores potential novel systems for treatment of addiction and prevention of overdose.

Entities:  

Keywords:  abuse-deterrent formulations; abuse-deterrent testing methods; nonprescription opioids; opioid abuse; opioid drugs

Mesh:

Substances:

Year:  2019        PMID: 30786212     DOI: 10.1146/annurev-bioeng-060418-052155

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  6 in total

1.  Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?

Authors:  Giuseppe Forte; Valentina Giuffrida; Angelica Scuderi; Mariella Pazzaglia
Journal:  Biomedicines       Date:  2022-06-10

2.  Nanotechnology for Pain Management: Current and Future Therapeutic Interventions.

Authors:  Divya Bhansali; Shavonne L Teng; Caleb S Lee; Brian L Schmidt; Nigel W Bunnett; Kam W Leong
Journal:  Nano Today       Date:  2021-06-19       Impact factor: 18.962

3.  Methylation quantitative trait locus rs5326 is associated with susceptibility and effective dosage of methadone maintenance treatment for heroin use disorder.

Authors:  Jianbo Zhang; Yajuan Fan; Jinting Zhou; Tengfei Ma; Keqiang Gao; Min Xu; Yifan Xiao; Yongsheng Zhu
Journal:  Psychopharmacology (Berl)       Date:  2021-09-03       Impact factor: 4.530

4.  Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.

Authors:  Farrokh Sharifi; Andrew Otte; Gwangheum Yoon; Kinam Park
Journal:  J Control Release       Date:  2020-07-07       Impact factor: 11.467

5.  Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation.

Authors:  Zhennan Zhao; Tingting Huang; Jiazhong Li
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

6.  Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose.

Authors:  Farrokh Sharifi; Yazan J Meqbil; Andrew Otte; Anna M Gutridge; Arryn T Blaine; Richard M van Rijn; Kinam Park
Journal:  Pharm Res       Date:  2021-06-10       Impact factor: 4.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.